These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3069643)

  • 21. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA; Salem HH
    Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer.
    Liebman HA; Comenzo R; Allen ST; Dilorio JM
    Am J Hematol; 1991 Sep; 38(1):24-9. PubMed ID: 1897511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of endothelium in the homeostatic balance of haemostasis.
    Nawroth P; Kisiel W; Stern D
    Clin Haematol; 1985 Jun; 14(2):531-46. PubMed ID: 2994930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system".
    Rosenberg RD; Bauer KA; Marcum JA
    J Med; 1985; 16(1-3):351-416. PubMed ID: 3915998
    [No Abstract]   [Full Text] [Related]  

  • 28. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function relationships of the thrombin-thrombomodulin interaction.
    Sadler JE; Lentz SR; Sheehan JP; Tsiang M; Wu Q
    Haemostasis; 1993 Mar; 23 Suppl 1():183-93. PubMed ID: 8388351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
    Preissner KT; Sié P
    Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin.
    Chan AK; Paredes N; Thong B; Chindemi P; Paes B; Berry LR; Monagle P
    Thromb Haemost; 2004 May; 91(5):1009-18. PubMed ID: 15116263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of abnormal antithrombin-III Toyama with cultured porcine aortic endothelial cells.
    Saito S; Takahashi K; Sakuragawa N
    Thromb Res; 1988 Apr; 50(1):19-25. PubMed ID: 3400080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.
    Nishinaga M; Ozawa T; Shimada K
    J Clin Invest; 1993 Sep; 92(3):1381-6. PubMed ID: 8376590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the coagulation system by vascular endothelial cells.
    Stern DM; Kaiser E; Nawroth PP
    Haemostasis; 1988; 18(4-6):202-14. PubMed ID: 2853122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation.
    Gil W
    Perfusion; 2001 Jan; 16(1):27-35. PubMed ID: 11192304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural anticoagulants.
    Salem HH
    Clin Haematol; 1986 May; 15(2):371-91. PubMed ID: 3015466
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells.
    Marcum JA; Rosenberg RD
    Biochem Biophys Res Commun; 1985 Jan; 126(1):365-72. PubMed ID: 3970699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys.
    Absher E; Labarrere CA; Carter C; Haag B; Faulk WP
    Transplantation; 1992 Apr; 53(4):828-34. PubMed ID: 1566349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for pericellular proteoglycan in the binding of thrombin or antithrombin III by the blood vessel endothelium? The effects of proteoglycan-degrading enzymes and glycosaminoglycan-binding proteins on 125I-thrombin binding by the rabbit thoracic aorta in vitro.
    Hatton MW; Moar SL
    Thromb Haemost; 1985 Apr; 53(2):228-34. PubMed ID: 4024034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anticoagulant role of heparin-like molecules in the endothelial cell surface in hemostasis--endothelial heparin-like molecules.
    Shimada K; Ozawa T
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1604-9. PubMed ID: 3551438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.